Stock Price

With strong Q3 results and key acquisitions, all eyes are on Addus HomeCare's year-end report to see if its growth momentum can be sustained.

Waters finalized its $18.8B merger with BD's units, doubling its size. But investor concerns over near-term performance sent shares tumbling.

Bionano's 2026 virtual event will showcase how Optical Genome Mapping is revolutionizing cancer and genetic disease research and paving a path to clinical use.

Safe Harbor Financial secures a landmark deal with PCCU, boosting revenue by $9M but taking on more risk. A bold move in the evolving cannabis finance world.

Following key permitting wins, Integra Resources' oversubscribed $61.6M financing signals strong investor faith and accelerates its DeLamar gold project.

Universal Corporation appoints Steven Diel, the mind behind its ingredients push, as CFO, signaling a firm commitment to diversification despite headwinds.

With its lead drug in Phase 3, Celldex will update investors at three major conferences, highlighting its immunology pipeline and financial strategy.

Fresh off its Nasdaq debut, adtech firm EVA Live is betting on its new NeuroServer AI, shelving a stock sale and eyeing a buyback to fuel growth.

PulteGroup's new director, a veteran of $150B in deals, signals a potential strategic shift amid a wave of homebuilding industry consolidation.

As ReNew prepares its Q3 FY26 report, all eyes are on the energy giant. Will its performance validate India's green transition and its own manufacturing bet?

IN8bio promotes Kate Rochlin to President, signaling a strategic push to advance its promising gamma-delta T cell pipeline amid a challenging market.

New drill results from Emerita's El Cura deposit show significant high-grade metals, boosting a key study and Europe's critical mineral supply chain.

With a promising spinal cord injury drug nearing late-stage trials, NervGen appoints interim leader Dr. Adam Rogers as permanent CEO to guide the breakthrough.

Semiconductor leader Astera Labs launches a new R&D hub in Israel, hiring top tech veterans to develop next-gen connectivity for the demanding AI era.

Backed by robust earnings and strategic acquisitions, Atmus Filtration's latest dividend signals strong financial health and a commitment to shareholder returns.

The Middle East healthcare giant posts record profits and a $163M dividend, fueled by aggressive international acquisitions and a major bet on AI technology.

The legal tech firm is cleared for trading after a two-month halt, now focusing on debt reduction using proceeds from a major UK asset divestiture.

Brazil's largest corn ethanol producer, FS, successfully refinances its debt, locking in lower rates and extending its financial runway to 2036.

Cantor Fitzgerald launches its 15th SPAC, raising $115M. With the market rebounding, will this bet on tech and healthcare pay off for investors?

A new class action lawsuit alleges Paysafe misled investors about major client risks and industry vulnerabilities, leading to a massive 27% stock drop.